FDA Import Refusal 799-9076841-8/11/1 — BEDI MEDICOSE
The FDA refused shipment 799-9076841-8/11/1 from BEDI MEDICOSE (India) on Jan 26, 2024. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Jan 26, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XCA45 CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
- Charges
- 75